Bernd Groner

Active 1977–2017

99
Papers
18,576
Citations
85
h-index
99
i10-index

Citations

Citations per year for Bernd Groner1962: 1 citations1977: 3 citations1978: 5 citations1979: 8 citations1980: 6 citations1981: 25 citations1982: 30 citations1983: 30 citations1984: 36 citations1985: 22 citations1986: 45 citations1987: 41 citations1988: 45 citations1989: 66 citations1990: 85 citations1991: 72 citations1992: 84 citations1993: 60 citations1994: 91 citations1995: 201 citations1996: 305 citations1997: 283 citations1998: 287 citations1999: 460 citations2000: 312 citations2001: 238 citations2002: 247 citations2003: 200 citations2004: 195 citations2005: 154 citations2006: 194 citations2007: 115 citations2008: 174 citations2009: 113 citations2010: 113 citations2011: 96 citations2012: 113 citations2013: 101 citations2014: 95 citations2015: 79 citations2016: 63 citations2017: 86 citations2018: 64 citations2019: 217 citations2020: 232 citations2021: 188 citations2022: 158 citations2023: 84 citations2024: 122 citations2025: 61 citations2026: 2 citations1963–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,123 citing papers, 37.4% of this breakdownGermany: 495 citing papers, 8.7% of this breakdownChina: 361 citing papers, 6.4% of this breakdownUnited Kingdom: 341 citing papers, 6% of this breakdownFrance: 241 citing papers, 4.2% of this breakdownJapan: 190 citing papers, 3.4% of this breakdownCanada: 177 citing papers, 3.1% of this breakdownSwitzerland: 171 citing papers, 3% of this breakdownItaly: 149 citing papers, 2.6% of this breakdownAustralia: 145 citing papers, 2.6% of this breakdownAustria: 106 citing papers, 1.9% of this breakdownSweden: 91 citing papers, 1.6% of this breakdown
0%37.4%Other 19.1%

Fields

  • Medicine51.3%
  • Biochemistry, Genetics and Molecular Biology32.4%
  • Immunology and Microbiology10%
  • Neuroscience1.9%
  • Agricultural and Biological Sciences0.8%
  • Chemistry0.5%
  • Other3.1%

Topics

  • Cytokine Signaling Pathways and Interactions9.4%
  • Immune Cell Function and Interaction2.9%
  • Monoclonal and Polyclonal Antibodies Research2.7%
  • Estrogen and related hormone effects2.2%
  • PI3K/AKT/mTOR signaling in cancer2%
  • HER2/EGFR in Cancer Research1.9%
  • Other78.9%

Coauthors

All papers

Open in search
  1. Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine

    Authors: , , , , , , , , , , , , , , , , , - Journal of Innate Immunity 2016 cited by 406

  2. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition

    Authors: , - Molecular and Cellular Endocrinology 2017 cited by 312

  3. Three-dimensional structure of the Stat3β homodimer bound to DNA

    Authors: , , - Nature 1998 cited by 792

  4. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1995 cited by 564

  5. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 206

  6. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

    Authors: , , , , , , , , , , - The EMBO Journal 2003 cited by 526

  7. The Coactivator of Transcription CREB-binding Protein Interacts Preferentially with the Glycosylated Form of Stat5

    Authors: , , , , , - Journal of Biological Chemistry 2004 cited by 169

  8. The function of Stat3 in tumor cells and their microenvironment

    Authors: , , - Seminars in Cell and Developmental Biology 2008 cited by 155

  9. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain

    Authors: , , , , , , , - Nature Medicine 1997 cited by 348

  10. Current strategies for the development of peptide‐based anti‐cancer therapeutics

    Authors: , , - Journal of Peptide Science 2005 cited by 159

  11. Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops

    Authors: , , , , , - Current Signal Transduction Therapy 2014 cited by 89

  12. Functional interactions between Stat5 and the glucocorticoid receptor

    Authors: , , , - Nature 1996 cited by 687

  13. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.

    Authors: , , , - The EMBO Journal 1994 cited by 598

  14. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients

    Authors: , , , , , , , , , , - Blood 1996 cited by 309

  15. IL‐10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes

    Authors: , , , , , - FEBS Letters 1996 cited by 169

  16. STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes

    Authors: , , , , , , , , , , , - Science Signaling 2014 cited by 167

  17. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.

    Authors: , , - The EMBO Journal 1994 cited by 841

  18. Thrombopoietin activates a STAT5‐like factor in hematopoietic cells.

    Authors: , , , , , , , , - The EMBO Journal 1995 cited by 216

  19. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer

    Authors: , , , , , - Oncogene 2011 cited by 119

  20. Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2

    Authors: , , , , , , , , , , , - Breast Cancer Research and Treatment 2003 cited by 95

  21. Distinct Roles for STAT1, STAT3, and STAT5 in Differentiation Gene Induction and Apoptosis Inhibition by Interleukin-9

    Authors: , , , , - Journal of Biological Chemistry 1999 cited by 94

  22. Mammary Epithelial Reconstitution with Gene-Modified Stem Cells Assigns Roles to Stat5 in Luminal Alveolar Cell Fate Decisions, Differentiation, Involution, and Mammary Tumor Formation

    Authors: , , , , , , , , , - Stem Cells 2010 cited by 78

  23. Prolactin regulation of beta‐casein gene expression and of a cytosolic 120‐kd protein in a cloned mouse mammary epithelial cell line.

    Authors: , , , , - The EMBO Journal 1988 cited by 514

  24. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

    Authors: , , , , , , , , , - 1994 cited by 467